J Am Pharm Assoc (2003). 2020 Jul-Aug;60(4):e52-e57. doi: 10.1016/j.japh.2019.12.021. Epub 2020 Feb 1.
Individuals with unrecognized atrial fibrillation (AF) may be at an increased risk of stroke. There is a need to develop a sustainable and reproducible population-based screening model to identify unrecognized AF.
The objective of this study is to evaluate AF screening and education at student pharmacist-driven health fairs.
Screening for AF was performed by student members of the American Pharmacist Association Academy of Student Pharmacists with preceptor oversight. Participants were screened using the KardiaMobile device (AliveCor, Mountain View, CA), a Food and Drug Administration-cleared device that interprets a medical-grade electrocardiogram in 30 seconds. Student pharmacists also calculated a CHA₂DS₂-VASc score. Participant education was provided using an American Heart Association AF patient information sheet. Learning assessment was evaluated with 3 multiple choice questions.
Students screened a total of 697 participants over a 6-month period at 13 health fairs. Overall, 71% of the participants were women aged 56 ± 15 years (mean ± SD). Sixteen of the participants (2.3%) who were screened received results indicating possible AF. None of the participants with a possible positive finding had symptoms suggestive of AF. Of these 16 participants, 11 (69%) had a CHA₂DS₂-VASc score greater than or equal to 2 (2.7 ± 0.7). Most participants answered each learning assessment question correctly. More than 95% of participants believed that screening for AF at health fairs was important or very important.
Student pharmacist-driven health fairs were shown to be feasible models to screen for AF and were effective in providing AF education to the public. Student pharmacists also cultivated a clinical skill that is transferable to their future practice setting, including the community pharmacy setting. Additional studies are needed to assess whether population-based real-time assessment and detection of AF can reduce the risk of stroke in individuals with previously undetected AF.
未被识别的心房颤动（房颤）患者可能面临更高的中风风险。因此，需要开发一种可持续且可重复的基于人群的筛查模型，以识别未被识别的房颤。
本研究旨在评估学生药剂师主导的健康博览会上的房颤筛查和教育。
由美国药剂师协会学生药剂师协会的学生成员在导师监督下进行房颤筛查。参与者使用 KardiaMobile 设备（AliveCor，加利福尼亚州山景城）进行筛查，这是一种经美国食品和药物管理局批准的设备，可在 30 秒内解读医疗级心电图。学生药剂师还计算了 CHA₂DS₂-VASc 评分。使用美国心脏协会房颤患者信息表提供参与者教育。通过 3 个多项选择题评估学习评估。
学生在 6 个月的 13 次健康博览会上共筛查了 697 名参与者。总体而言，参与者中有 71%为女性，年龄为 56±15 岁（均值±标准差）。在接受筛查的参与者中，有 16 名（2.3%）的筛查结果显示可能存在房颤。没有任何可能出现阳性发现的参与者出现房颤的症状。在这 16 名参与者中，有 11 名（69%）的 CHA₂DS₂-VASc 评分大于或等于 2（2.7±0.7）。大多数参与者正确回答了每个学习评估问题。超过 95%的参与者认为在健康博览会上筛查房颤很重要或非常重要。
学生药剂师主导的健康博览被证明是筛查房颤的可行模式，并且有效地向公众提供了房颤教育。学生药剂师还培养了一种可转移到未来实践环境（包括社区药房环境）的临床技能。需要进一步研究来评估基于人群的实时房颤评估和检测是否可以降低以前未被发现的房颤患者中风的风险。
